BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
Metabolism of xenobiotics
,
Influenza
,
Prostate
,
Biofuel
,
Trichostatin A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SA 1
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Oral squamous cell carcinoma cell lines treated with 5-aza-2'-deoxycytidine (AzC)
HAI-1 knockdown in oral squamous cell carcinoma cell line SAS
Tongue squamous cell carcinoma SAS cells with AURKA siRNA knockdown
Tongue carcinoma SAS cells with AKT1 siRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Different NIPBL requirements of cohesin-STAG1 and cohesin-STAG2.
Periosteal Fasciitis With Unusual Radiologic Features Harboring a Novel STAG1::USP6 Fusion Gene.
Novel STAG1 Frameshift Mutation in a Patient Affected by a Syndromic Form of Neurodevelopmental Diso…
Protective role of complement factor H against the development of preeclampsia.
Identification of complement factor H variants that predispose to pre-eclampsia: A genetic and funct…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immunogenicity of SA 14-14-2 JE Vaccine
Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease
A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insuf…
Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets an…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ